The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities
- PMID: 25288423
- PMCID: PMC4591849
- DOI: 10.1377/hlthaff.2014.0540
The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities
Abstract
The federal 340B program gives participating hospitals and other medical providers deep discounts on outpatient drugs. Named for a section of the Veterans Health Care Act of 1992, the program's original intent was to help low-income and uninsured patients. But the program has come under scrutiny by critics who contend that some hospitals exploit the drug discounts to generate profits instead of either investing in programs for the poor or passing the discounts along to patients and insurers. We examined whether the program is expanding in ways that could maximize hospitals' ability to generate profits from the 340B drug discounts. We matched data for 960 hospitals and 3,964 affiliated clinics registered with the 340B program in 2012 with the socioeconomic characteristics of their communities from the US Census Bureau's American Community Survey. We found that hospital-affiliated clinics that registered for the 340B program in 2004 or later served communities that were wealthier and had higher rates of health insurance compared to communities served by hospitals and clinics that registered for the program before 2004. Our findings support the criticism that the 340B program is being converted from one that serves vulnerable patient populations to one that enriches hospitals and their affiliated clinics.
Keywords: Hospitals; Medicare; Pharmaceuticals.
Project HOPE—The People-to-People Health Foundation, Inc.
Figures




Similar articles
-
The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.Health Aff (Millwood). 2014 Nov;33(11):2012-7. doi: 10.1377/hlthaff.2014.0833. Health Aff (Millwood). 2014. PMID: 25367997 Free PMC article.
-
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.JAMA Netw Open. 2019 Oct 2;2(10):e1914141. doi: 10.1001/jamanetworkopen.2019.14141. JAMA Netw Open. 2019. PMID: 31664442 Free PMC article.
-
Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.Food Drug Law J. 2015;70(4):481-99, i. Food Drug Law J. 2015. PMID: 26827389
-
The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.Health Care Manag (Frederick). 2019 Oct/Dec;38(4):311-321. doi: 10.1097/HCM.0000000000000279. Health Care Manag (Frederick). 2019. PMID: 31663869
-
A comparison of medication access services at 340B and non-340B hospitals.Res Social Adm Pharm. 2021 Nov;17(11):1887-1892. doi: 10.1016/j.sapharm.2021.03.010. Epub 2021 Mar 20. Res Social Adm Pharm. 2021. PMID: 33846100 Review.
Cited by
-
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.Milbank Q. 2024 Jun;102(2):429-462. doi: 10.1111/1468-0009.12691. Epub 2024 Jan 28. Milbank Q. 2024. PMID: 38282421 Free PMC article.
-
Outpatient chemotherapy drug costs and expensive chemotherapy drug use in 340B and Non-340B hospitals: an observational study.BMC Health Serv Res. 2025 Jan 28;25(1):157. doi: 10.1186/s12913-024-12188-1. BMC Health Serv Res. 2025. PMID: 39871245 Free PMC article.
-
The 340B Program and oral specialty drugs for advanced prostate cancer.Cancer. 2024 Jun 15;130(12):2160-2168. doi: 10.1002/cncr.35262. Epub 2024 Feb 23. Cancer. 2024. PMID: 38395607 Free PMC article.
-
Has The Era Of Slow Growth For Prescription Drug Spending Ended?Health Aff (Millwood). 2016 Sep 1;35(9):1595-603. doi: 10.1377/hlthaff.2015.1636. Health Aff (Millwood). 2016. PMID: 27605638 Free PMC article.
-
Review of Current Policy Strategies to Reduce US Cancer Drug Costs.J Clin Oncol. 2020 Feb 1;38(4):372-379. doi: 10.1200/JCO.19.01628. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804856 Free PMC article. Review. No abstract available.
References
-
- Government Accountability Office. Drug pricing: manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement [Internet] Washington (DC): GAO; 2011. Sep, [cited 2014 Aug 28]. Available from: http://gao.gov/assets/330/323702.pdf.
-
- Grassley CE. Letter to Mary K. Wakefield [Internet] Washington (DC): Senate Committee on the Judiciary; 2013. Mar 27, [cited 2014 Aug 28]. Available from: http://www.grassley.senate.gov/sites/default/files/about/upload/2013-03-....
-
- Alexander A, Garloch K, Neff J. Nonprofit hospitals thrive on profits. Charlotte Observer. 2012 Apr 21;
-
- Pollack A. Dispute develops over discount drug program. New York Times. 2013 Feb 12;
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources